Biography:
Farazul Hoda, is currently a PhD research scholar at Jamia Hamdard’s School of Pharmaceutical Education & Research, New Delhi, specializing in Type 2 Diabetes Mellitus and its complications, including diabetic kidney disease. His recent work includes a cross-sectional study on dp ucMGP as a biomarker for early DKD detection in T2DM patients, published in Nephrology (Carlton) in May 2025. Earlier, he co-led an mHealth randomized clinical trial demonstrating significant improvements in glycaemic control. He also authored a systematic review in Drug Research on Nigella sativa’s effects on blood glucose in T2DM. With over 135 citations on Google Scholar, Farazul brings strong expertise in clinical trials, biomarker research, and telehealth interventions. His multidisciplinary approach combining pharmacology, endocrinology, and digital health aims to improve patient outcomes and inform diabetes care innovation in India.
Title : Diagnostic potential of Dp-ucMGP as a biomarker for early detection of diabetic kidney disease in patients with type 2 diabetes mellitus: A cross-sectional study